Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. May 6, 2017; 8(2): 131-136
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.131
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.131
Table 4 Infusion time and indirect cost savings: Traditional vs short infusion protocol
| w/out SI (min) | w SI (min) | Delta (min) | Saving (min) | Delta % | Hours | Saving indirect costs (€) | |
| Infusion time | 300120 | 254400 | -45.72 | -45720 | -15% | -762 | -11.525 |
| Post infusion time | 225090 | 202230 | -22.86 | -22860 | -10% | -381 | -5.763 |
| Total time | 525210 | 456630 | -68.58 | -68580 | -13% | -1143 | -17.288 |
| Costsaving/patient | -9 | -138 |
- Citation: Viola A, Costantino G, Privitera AC, Bossa F, Lauria A, Grossi L, Principi MB, Della Valle N, Cappello M. Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study. World J Gastrointest Pharmacol Ther 2017; 8(2): 131-136
- URL: https://www.wjgnet.com/2150-5349/full/v8/i2/131.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i2.131